Page 83 - GPD-3-2

Gene & Protein in Disease Opportunities and challenges of HIF-1 in cancer

doi: 10.1101/2022.06.15.492526 doi: 10.1016/j.actbio.2020.12.036
101. Syukri A, Budu HM, Amir M, et al. Doxorubicin induced 111. Huang R, Zhou PK. HIF-1 signaling: A key orchestrator of
immune abnormalities and inflammatory responses via cancer radioresistance. Radiat Med Protect. 2020;1(1):7-14.
HMGB1, HIF1-α and VEGF pathway in progressive doi: 10.1016/j.radmp.2020.01.006
of cardiovascular damage. Ann Med Surg (Lond).
2022;76:103501. 112. Multhoff G, Radons J, Vaupel P. Critical role of aberrant
angiogenesis in the development of tumor hypoxia and
doi: 10.1016/j.amsu.2022.103501 associated radioresistance. Cancers (Basel). 2014;6(2):813-828.
102. Xu L, Zhang Z, Ding Y, et al. Bifunctional liposomes reduce doi: 10.3390/cancers6020813
the chemotherapy resistance of doxorubicin induced by
reactive oxygen species. Biomater Sci. 2019;7(11):4782-4789. 113. Boulefour W, Rowinski E, Louati S, et al. A review of the
role of hypoxia in radioresistance in cancer therapy. Med
doi: 10.1039/C9BM00590K Sci Monit. 2021;27:e934116.
103. Xiang L, Wang Y, Lan J, et al. HIF-1-dependent heme doi: 10.12659/MSM.934116
synthesis promotes gemcitabine resistance in human non-
small cell lung cancers via enhanced ABCB6 expression. 114. Calvo-Asensio I, Dillon ET, Lowndes NF, Ceredig R. The
Cell Mol Life Sci. 2022;79(6):343. transcription factor Hif-1 enhances the radio-resistance of
mouse MSCs. Front Physiol. 2018;9:439.
doi: 10.1007/s00018-022-04360-9
doi: 10.3389/fphys.2018.00439
104. Runglawan S, Yingpinyapat K, Suyanee T, et al. Potential
role of HIF-1-responsive MicroRNA210/hif3 axis on 115. Wiechec E, Matic N, Ali A, Roberg K. Hypoxia induces
gemcitabine resistance in cholangiocarcinoma cells. PLoS radioresistance, epithelialmesenchymal transition, cancer
stem celllike phenotype and changes in genes possessing
One. 2018;13(6):e0199827.
multiple biological functions in head and neck squamous
doi: 10.1371/journal.pone.0199827 cell carcinoma. Oncol Rep. 2022;47(3):58.
105. Zhao T, Ren H, Jia L, et al. Inhibition of HIF-1α by doi: 10.3892/or.2022.8269
PX-478 enhances the anti-tumor effect of gemcitabine
by inducing immunogenic cell death in pancreatic ductal 116. Hennessey D, Martin LM, Atzberger A, Lynch TH,
Hollywood D, Marignol L. Exposure to hypoxia following
adenocarcinoma. Oncotarget. 2014;6(4):2250-2262. irradiation increases radioresistance in prostate cancer
doi: 10.18632/oncotarget.2948 cells. Urol Oncol. 2013;31(7):1106-1116.
106. Wouters A, Pauwels B, Burrows N, et al. The radiosensitising doi: 10.1016/j.urolonc.2011.10.008
effect of gemcitabine and its main metabolite DFdU 117. Kabakov AE, Yakimova AO. Hypoxia-induced cancer
under low oxygen conditions is in vitro not dependent on cell responses driving radioresistance of hypoxic tumors:
functional HIF-1 protein. BMC Cancer. 2014;14(1):594. Approaches to targeting and radiosensitizing. Cancers
doi: 10.1186/1471-2407-14-594 (Basel). 2021;13(5):1102.
107. Kang G, Hu M, Ren H, et al. VHH212 nanobody targeting doi: 10.3390/cancers13051102
the hypoxia-inducible factor 1α suppresses angiogenesis 118. Domènech M, Hernández A, Plaja A, Martínez-Balibrea E,
and potentiates gemcitabine therapy in pancreatic cancer Balañà C. Hypoxia: The cornerstone of glioblastoma. Int J
in vivo. Cancer Biol Med. 2021;18(3):772-787. Mol Sci. 2021;22(22):12608.
doi: 10.20892/j.issn.2095-3941.2020.0568 doi: 10.3390/ijms222212608
108. Wang X, Zhong X, Liu Z, Cheng L. Recent progress of 119. Feng H, Wang J, Chen W, et al. Hypoxia-induced autophagy
chemodynamic therapy-induced combination cancer as an additional mechanism in human osteosarcoma
therapy. Nano Today. 2020;35:100946. radioresistance. J Bone Oncol. 2016;5(2):67-73.
doi: 10.1016/j.nantod.2020.100946 doi: 10.1016/j.jbo.2016.03.001
109. Zhang X, He C, He X, et al. HIF-1 inhibitor-based one-stone- 120. Guo D, Jin J, Liu J, Wang Y, Li D, He Y. Baicalein inhibits the
two-birds strategy for enhanced cancer chemodynamic- progression and promotes radiosensitivity of esophageal
immunotherapy. J Controll Rel. 2023;356:649-662. squamous cell carcinoma by targeting HIF-1A. Drug
doi: 10.1016/j.jconrel.2023.03.026 Design Devel Ther. 2022;16:2423-2436.
110. He C, Zhang X, Chen C, et al. A solid lipid coated calcium doi: 10.2147/dddt.s370114
peroxide nanocarrier enables combined cancer chemo/ 121. Zeng X, Wan L, Wang Y, Xue J, Yang H, Zhu Y. Effect of low
chemodynamic therapy with O /H O self-sufficiency. Acta dose of berberine on the radioresistance of cervical cancer
2
2
2
Biomater. 2021;122:354-364. cells via a PI3K/HIF-1 pathway under nutrient-deprived
Volume 3 Issue 2 (2024) 16 doi: 10.36922/gpd.3431